Skip to content

Study · Non-randomized trial · n = 24 · 1990

1 result

Antiendometrial antibodies in endometriosis measured by an enzyme-linked immunosorbent assay before and after treatment with danazol and nafarelin.

Kennedy SH, Starkey PM, Sargent IL, Hicks BR, Barlow DH

Obstetrics and gynecology1 Jun 1990Cited by 41 (Europe PMC)

PMID2140439 (opens in a new tab)PepBankPUB-02140439
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanNon-randomized trialMechanism

    In women with endometriosis, antiendometrial antibody levels decreased significantly during nafarelin treatment (P less than .001).

    In plain wordsIn women with endometriosis, antiendometrial antibody levels decreased during nafarelin treatment.

    Peptide
    Nafarelin
    Outcome
    DecreaseAntiendometrial antibodies
    Study

    n = 24

    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated · 6 monthsAs given in this study (human).

    Measurements

    P value
    < 0.001
    nafarelin change

    Source sentences

    Summary
    Levels were lowered by treatment, but to a significant extent only in the nafarelin group (P less than .001) (danazol group: P = .091).
    1 context sentence
    Summary · context
    We measured antiendometrial antibody levels by an enzyme-linked immunosorbent assay in 35 women with laparoscopically proved endometriosis who were treated for 6 months with danazol (N = 11) or nafarelin (N = 24) in a randomized double-blind study.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:36 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.